We are live on
!
Find out more
CG
CFO4Life Group Portfolio holdings
AUM
$656M
1-Year Est. Return
17.88%
This Fund
S&P 500
This Quarter
Est. Return
-4.97%
1 Year Est. Return
+17.88%
3 Year Est. Return
+43.38%
5 Year Est. Return
+49.69%
10 Year Est. Return
–
AUM
$433M
AUM Growth
-$32.9M
(-7.1%)
Cap. Flow
-$7.74M
Cap. Flow
% of AUM
-1.79%
Top 10 Holdings %
Top 10 Hldgs %
57.73%
Holding
187
New
8
Increased
58
Reduced
85
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$1.42M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.21M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$933K |
| 4 |
First Trust Smith Unconstrained Bond ETF
UCON
|
+$825K |
| 5 |
Salesforce
CRM
|
+$744K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Darling Ingredients
DAR
|
+$7M |
| 2 |
Lennox International
LII
|
+$2.44M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$825K |
| 4 |
AYX
Alteryx Inc
AYX
|
+$644K |
| 5 |
Analog Devices
ADI
|
+$631K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.01% |
| 2 | Technology | 11.19% |
| 3 | Consumer Staples | 7.02% |
| 4 | Financials | 6.32% |
| 5 | Consumer Discretionary | 4.24% |
Similar funds
BL
DAS
VCM
W
GPSPJS
PAI
RRA
FMN
CFO4Life Group's Q3 2023 Portfolio in Review
As of Q3 2023, CFO4Life Group held 187 positions worth $433M, down 7.1% from $466M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
CFO4Life Group's Q3 2023 filing shows 8 new, 58 increased, 85 reduced and 16 closed positions. Its largest new stake was Salesforce: 3,445 shares worth $699K. The largest sale was Darling Ingredients, an estimated $7M.
By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Staples.
- CFO4Life Group's largest Q3 2023 buy was Salesforce: 3,445 shares worth $699K.
- CFO4Life Group added most to JPMorgan Equity Premium Income ETF in Q3 2023, an estimated $1.42M increase.
- CFO4Life Group's biggest Q3 2023 reduction was Darling Ingredients, cutting an estimated $7M.
- CFO4Life Group fully exited Thermo Fisher Scientific in Q3 2023, selling an estimated $825K.
- CFO4Life Group's ten largest holdings make up 58% of its $433M portfolio in Q3 2023.
- CFO4Life Group opened 8 new positions and closed 16 in Q3 2023.
- CFO4Life Group's portfolio value fell 7.1% quarter-over-quarter to $433M.
Based on CFO4Life Group's 13F filing for Q3 2023, filed 30 Oct 2023.